
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial for Major Depressive Disorder
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase I/IIa clinical trial for its lead product, SPL026,











